Sigma3 SP LLC closed on an agreement with the University of Washington (UW) in Seattle to have the rights for the newest noise suppression software from Dr. Patricia Kuhl’s ILabs’ team Samu Taulu and Eric Larson, both of whom advise for Sigma3. This team’s first software (Denoise1) to suppress internal sensors’ noise was the impetus to establish the Sigma3 SP LLC company. That software has been used extensively by several Japanese researchers.
The second software (Denoise2) was first presented by Dr. Taulu in an August 2020 Japan Human Brain Mapping lecture. This software will have applications for not only magnetoencephalography but also electroencephalography (EEG.) In fact, Denoise2 is mainly directed to EEG devices where signal components separation may not be possible, for example, due to a small number of channels or modest inaccuracies.
Unlike where Sigma3 only applied for the Denoise1 patent in the United States, the company worked with CoMotion, UW’s collaborative innovation hub, to expand the Denoise2 patents for US, Japan, and selective European countries.
“We feel strongly that Denoise2 has the potential to aid EEG users worldwide. Sigma3 also wants to thank the excellent guidance we received from Lisa Norton, Patrick Chinkiwsky, and their colleagues at CoMotion,” said Stephen Otto CEO of Sigma3. “We know there are others working on these types of EEG issues, but we believe this may be quite a unique and powerful approach.”
Dr. Taulu further explained, “We believe others are using a data-driven method as opposed to our physical model, which usually leads to more robust results.”
For further information on this software or about Sigma3 SP LLC, please send inquiries to Stephen Otto, Sigma3’s Chief Executive Officer at [email protected].